Novavax to Present at the Stifel 2017 Healthcare Conference

YASTEST

GAITHERSBURG, Md., Nov.  08, 2017  (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will present at the Stifel 2017 Healthcare Conference.

Presentation details are as follows:

Date: Wednesday, November 15, 2017
Time: 1:15 p.m. - 1:55 p.m. ET
Location: Garrison, 5^th Floor, Lotte New York Palace Hotel, New York City
Live webcast: www.novavax.com, "Investors"/"Events"

A replay of the presentation will also be accessible under the "Investors/Events" section of the Novavax website at novavax.com.

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com.

Contact:

Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Director, Investor & Media Relations
[e-mail] 
240-268-2000

Westwicke Partners
John Woolford
[e-mail]
443-213-0506

Media
Russo Partners, LLC
David Schull
Maggie Beller
[e-mail]
[e-mail]
212-845-4271

---

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novavax, Inc. via Globenewswire